Pain News and Research

Latest Pain News and Research

Enhanced recovery pathway recovers patients undergoing gynecologic surgery more quickly

Patients who had complex gynecologic surgery managed by an enhanced recovery pathway resulted in decreased narcotic use, earlier discharge, stable readmission rates, excellent patient satisfaction and cost savings, according to a Mayo Clinic study.

27 Aug 2013

tDCS for 15 days improves sleep and fatigue symptoms in patients with PPS

Of the 15 million people around the world who have survived poliomyelitis, up to 80% report progressive deteriorating strength and endurance many years after infection, a condition known as post-polio syndrome (PPS).

27 Aug 2013

Enhanced recovery pathway for patients undergoing gynecologic surgery recovers more quickly

Patients who had complex gynecologic surgery managed by an enhanced recovery pathway (ERP) resulted in decreased narcotic use, earlier discharge, stable readmission rates, excellent patient satisfaction and cost savings, according to a Mayo Clinic study. The findings are published in the journal Obstetrics & Gynecology.

27 Aug 2013

Sanofi Pasteur reports clinical benefit of Fluzone High-Dose vaccine in preventing influenza

Sanofi Pasteur, the vaccines division of Sanofi, today announced topline results of a large-scale, multi-center efficacy trial in people 65 years of age and older showing a superior clinical benefit of Fluzone High-Dose (Influenza Virus Vaccine) relative to the standard dose of Fluzone vaccine in preventing influenza.

26 Aug 2013

Teleflex to showcase anesthesia and pain management products at ESRA Congress

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, will showcase its regional anesthesia and pain management products featuring improved practices during the ESRA Congress in Glasgow, UK, on September 4-7, 2013.

26 Aug 2013

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.

26 Aug 2013

Immune Pharmaceuticals announces completion of merger with EpiCept Corporation

Immune Pharmaceuticals Inc. announced today the completion of the merger of Immune Pharmaceuticals Ltd. and EpiCept Corporation.

26 Aug 2013

Innovation that speeds up pure oxygen production wins 2013 Curtin Commercial Innovation Awards

An innovation that speeds up pure oxygen production, a medical device that treats neck pain and technology that regenerates tissue in ulcers are the winners of the 2013 Curtin Commercial Innovation Awards.

23 Aug 2013

First Edition: August 23, 2013

Today's headlines include reports on what's becoming of the potential for a deficit deal, as well as the political posturing related to the House GOP efforts to block health law funding even if it means shutting down the government.

23 Aug 2013

Study suggests that human brains are hardwired to empathize with friends, spouses

Perhaps one of the most defining features of humanity is our capacity for empathy - the ability to put ourselves in others' shoes. A new University of Virginia study strongly suggests that we are hardwired to empathize because we closely associate people who are close to us - friends, spouses, lovers - with our very selves.

23 Aug 2013

Report shows nonmedical use of pain relievers may increase risk of using heroin later

A new report by the Substance Abuse and Mental Health Services Administration (SAMHSA) shows that people aged 12 to 49 who had used prescription pain relievers nonmedically were 19 times more likely to have initiated heroin use recently (within the past 12 months of being interviewed) than others in that age group (0.39 percent versus 0.02 percent).

23 Aug 2013

New radiation treatment can reduce bone pain, extend lives of prostate cancer patients

Prostate cancer that has spread to the bones can cause pain and fractures. Loyola University Medical Center is among the first hospitals in Chicago to offer a new targeted radiation treatment that can reduce bone pain and the incidence of fractures - and also extend patients' lives.

23 Aug 2013

Four simple steps increase chances of preoperative smoking cessation

A simple four-part program-including referral to a quit-smoking hotline and a free supply of nicotine patches-can increase the percentage of patients who quit smoking before undergoing surgery, reports a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

23 Aug 2013

Aromatherapy, IV dextrose may relieve nausea and vomiting after surgery

Two simple, non-drug treatments-aromatherapy and intravenous administration of a simple sugar solution-may offer effective new approaches to relieving nausea and vomiting after surgery, report a pair of studies in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

22 Aug 2013

PDI Expands Focus With Mdx Commercialization Deal

...

22 Aug 2013

New Pharmacological Drug Target Identified In The Brain

...

22 Aug 2013

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.

22 Aug 2013

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Takeda Pharmaceutical Company Limited today announced that results from two Phase 3 studies evaluating vedolizumab, an investigational humanized monoclonal antibody, for the treatment of adults with moderately to severely active ulcerative colitis and Crohn’s disease, were published in the August 22, 2013 issue of the New England Journal of Medicine.

22 Aug 2013

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Novartis announced today that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2013-2014 season. Novartis plans to ship a minimum of 30 million doses of its influenza vaccines to the US market, including Fluvirin (Influenza Virus Vaccine), approved for use in people 4 years of age and older, and Flucelvax (Influenza Virus Vaccine), approved for use in adults 18 years of age and older.

22 Aug 2013

Study looks at cost benefits of knee replacement surgery relative to societal, economic savings

The full impact of knee replacement surgery on both patients' lives and on society includes significant overall cost savings, according to a new study published in the Journal of Bone and Joint Surgery.

22 Aug 2013

Pain News and Research

Latest Pain News and Research

Enhanced recovery pathway recovers patients undergoing gynecologic surgery more quickly

tDCS for 15 days improves sleep and fatigue symptoms in patients with PPS

Enhanced recovery pathway for patients undergoing gynecologic surgery recovers more quickly

Sanofi Pasteur reports clinical benefit of Fluzone High-Dose vaccine in preventing influenza

Teleflex to showcase anesthesia and pain management products at ESRA Congress

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Immune Pharmaceuticals announces completion of merger with EpiCept Corporation

Innovation that speeds up pure oxygen production wins 2013 Curtin Commercial Innovation Awards

First Edition: August 23, 2013

Study suggests that human brains are hardwired to empathize with friends, spouses

Report shows nonmedical use of pain relievers may increase risk of using heroin later

New radiation treatment can reduce bone pain, extend lives of prostate cancer patients

Four simple steps increase chances of preoperative smoking cessation

Aromatherapy, IV dextrose may relieve nausea and vomiting after surgery

PDI Expands Focus With Mdx Commercialization Deal

New Pharmacological Drug Target Identified In The Brain

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Study looks at cost benefits of knee replacement surgery relative to societal, economic savings

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Pain News and Research

Latest Pain News and Research

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in